Document is current
Any future updates will be listed below
-
Authors
Liu, Yuxi
Xue, Honghong
Wong, Wendy
Ding, Haifeng
Chen, Mingyang
Xie, Tong
Wan, Chonghua
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (71373058)
- License Information
-
More Information
Article History
Received: 19 September 2023
Accepted: 26 August 2024
First Online: 9 September 2024
Competing interests
: The authors declare no competing interests.
: The study protocol was approved by the Institutional Review Board (IRB) of the first affiliated hospital of Guangdong medical university (PJ2013037). The investigators explained the aims of the trial and the instrument to the patients older than 16 years and obtained informed consent from those patients who agreed to participate in the study and met with the inclusion criteria. The informed consent has been obtained from their parents for study participation for minors under 16 years old.
: A complete assurance was given that all information would be kept confidential. The right was given to the patients not to participate and to discontinue participation in the study with consideration/without penalty. The Declaration of Helsinki’s ethical guidelines were followed in the study.
